@silencetheraplc : At the recent 22nd Closed Scientific Meeting of @PCSK9Forum, our Chief Scientific Officer, Marie Wikström Lindholm, shared how Silence applies a powerful combination of machine learning and in silico prediction to narrow the field – maximizing activity and minimizing off-target • TwiCopy

Silence Therapeutics

@silencetheraplc

+ Follow

We are developing a new generation of medicines by harnessing the body’s natural mechanism of RNA interference. Nasdaq:SLN Guidelines: bit.ly/3iYc2sP

ID: 388149804

linkhttp://silence-therapeutics.com calendar_today10-10-2011 08:31:00

1,1K Tweet

3,3K Followers

690 Following

Silence Therapeutics

@silencetheraplc

a month ago

At the recent 22nd Closed Scientific Meeting of PCSK9 Forum, our Chief Scientific Officer, Marie Wikström Lindholm, shared how Silence applies a powerful combination of machine learning and in silico prediction to narrow the field – maximizing activity and minimizing off-target

At the recent 22nd Closed Scientific Meeting of <a href="/PCSK9Forum/">PCSK9 Forum</a>, our Chief Scientific Officer, Marie Wikström Lindholm, shared how Silence applies a powerful combination of machine learning and in silico prediction to narrow the field – maximizing activity and minimizing off-target

thumb_up_off_alt2

chat_bubble_outline0

repeat0

shareShare